Herein we describe the inhibitory effect of the synthetic peptide Abeta1-40, homologous to the major high-density lipoprotein-associated species of Alzheimer's amyloid beta protein (Abeta), on lipid biosynthesis in human hepatic HepG2 cells. This culture synthesizes various lipids from [14C]acetate as a precursor. Treatment of cells with different concentrations of Abeta1-40 decreased the syntheses of various radiolabeled lipid species. The decrease reached saturation at peptide concentrations equal to 10-100 ng ml(-1). The lipids whose synthesis was decreased most were free and esterified cholesterol and phospholipids. This inhibitory effect suggests that Abeta protein may modulate physiological intracellular lipid syntheses. It may also be of special importance in the pathological condition, and contribute to the neurodegeneration, in Alzheimer's disease and related disorders.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0014-5793(96)01042-3DOI Listing

Publication Analysis

Top Keywords

peptide abeta1-40
8
lipid biosynthesis
8
hepg2 cells
8
multiple inhibitory
4
inhibitory effects
4
effects alzheimer's
4
alzheimer's peptide
4
lipid
4
abeta1-40 lipid
4
biosynthesis cultured
4

Similar Publications

Efficient Seeding of Cerebral Vascular Aβ-Amyloidosis by Recombinant AβM1-42 Amyloid Fibrils.

J Mol Biol

February 2025

Department of Physics, Chemistry and Biology (IFM), Linköping University, 581 83 Linköping, Sweden. Electronic address:

Aβ-amyloid plaques and cerebral amyloid angiopathy (CAA) in the brain are pathological hallmarks of Alzheimer's disease (AD) and vascular dementia. The spreading of Aβ amyloidosis in the brain appears to be mediated by a seeding mechanism, where preformed fibrils (called seeds) accelerate Aβ fibril formation by bypassing the rate-determining nucleation step. Several studies have demonstrated that Aβ amyloidosis can be induced in transgenic mice, producing human Aβ, by injecting Aβ-rich brain extracts (seeds) derived from transgenic mice and human AD brains.

View Article and Find Full Text PDF

A comparison of cognitive decline in aged mice and mice treated with aftin-4.

Sci Rep

November 2024

Institute of Preclinical Sciences, Veterinary Faculty, University of Ljubljana, Gerbičeva 60, Ljubljana, 1000, Slovenia.

Dementia, especially Alzheimer's disease, presents a major clinical challenge, and researchers are still searching for an optimal animal model. To address this gap, we compared male and ovariectomized female C57BL/6 mice treated with 30 mg/kg aftin-4, which induces neurodegeneration, with naturally aged (15-16 months old) mice not treated with aftin-4. We performed a series of behavioral tests; measured postmortem plasma β-amyloid levels (Aβ1-40 and Aβ1-42) and the levels of the oxidative stress indicators glutathione peroxidase (GPx), superoxide dismutase (SOD) and malondialdehyde (MDA); and evaluated astrocytic reactivity in the brain using glial fibrillary acid protein (GFAP) levels.

View Article and Find Full Text PDF

Acorus tatarinowii alleviates D-galactose-induced Alzheimer's-like disease cognitive impairment and Aβ-induced pericytes dysfunction in mice.

Brain Res

January 2025

State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Tianjin Key Laboratory of Traditional Chinese Medicine Pharmacology, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China. Electronic address:

Pericytes regulate cerebral blood flow (CBF) and excess amyloid in the brain. Pericyte dysfunction may contribute to the pathology of Alzheimer's disease (AD). Acorus tatarinowii (AT), a Chinese medicine commonly used to treat AD, protects the central nervous system.

View Article and Find Full Text PDF
Article Synopsis
  • - The amyloid β peptide (Aβ3pE-42), linked to Alzheimer's disease, is known to accumulate in the brain, and a therapeutic antibody called donanemab has shown promise in clinical trials for treating it.
  • - Research indicates that Aβ3pE-42 is more stable than other variants and its accumulation is influenced by a deficiency in neprilysin, an enzyme that typically breaks down Aβ, which leads to its selective deposition in mouse models.
  • - The study suggests that treatments targeting Aβ3pE-42 may be more successful if administered prior to its accumulation in the brain, highlighting the importance of timing in anti-Aβ therapies.
View Article and Find Full Text PDF

Objective: This study aimed to explore the mechanism by which noise contributes to the development of Alzheimer's disease (AD)-like lesions.

Method: Male Wistar rats (24 months) were allocated into two groups (n = 6 per groups): a noise group exposed to 98 dB sound pressure-level white noise for 4 hours daily from 8:00 to 12:00 for 30 days, and a control group without noise exposure. The cognitive functions of the rats were assessed using new-object recognition and Morris water maze tests.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!